AEON MEDIX INC has a total of 25 patent applications. Its first patent ever was published in 2010. It filed its patents most often in WIPO (World Intellectual Property Organization), Republic of Korea and China. Its main competitors in its focus markets pharmaceuticals, biotechnology and agriculture are PHARMING INTELLECTUAL PROPERTY B V, SAMARITAN PHARMACEUTICALS INC and CYTOCHROMA INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | Republic of Korea | 5 | |
#3 | China | 4 | |
#4 | United States | 4 | |
#5 | EPO (European Patent Office) | 3 | |
#6 | Australia | 1 | |
#7 | Brazil | 1 | |
#8 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Agriculture | |
#4 | Measurement | |
#5 | Micro-structure and nano-technology | |
#6 | Environmental technology | |
#7 | Machines |
# | Name | Total Patents |
---|---|---|
#1 | Gho Yong Song | 23 |
#2 | Kim Yoon Keun | 23 |
#3 | Hong Bok Sil | 9 |
#4 | Jang Su Chul | 9 |
#5 | Kim Oh Youn | 9 |
#6 | Hong Sung Wook | 8 |
#7 | Lee Eun Young | 8 |
#8 | Kim Ji Hyun | 8 |
#9 | Lee Won Hee | 6 |
#10 | Park Kyoung Su | 5 |
Publication | Filing date | Title |
---|---|---|
AU2011271830A1 | Microvesicles derived from cell protoplast, and use thereof | |
KR20120114872A | Extracellular vesicles derived from genus acinetobacter and use thereof | |
EP2486940A2 | Composition comprising extracellular membrane vesicles derived from indoor air, and use thereof | |
KR20110025068A | Extracellular vesicles derived from gut microbiota, and disease models, vaccines, drug screening methods, and diagnostic methods using the same | |
CN102596177A | Microvesicles derived from nucleated, mammalian cells and use thereof | |
WO2011027956A2 | Extracellular vesicles derived from gram-positive bacteria, and disease model using same |